Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
466.7 USD | +2.49% | +4.48% | +14.75% |
05-31 | BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480 | MT |
05-31 | Vertex Pharmaceuticals Insider Sold Shares Worth $1,478,068, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.75% | 118B | |
+13.61% | 106B | |
-2.04% | 24.28B | |
+0.70% | 21.96B | |
-9.26% | 18.16B | |
-42.28% | 16.37B | |
-17.16% | 15.56B | |
+6.22% | 13.63B | |
+29.30% | 12.27B | |
+85.46% | 8.87B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated - Special Call